Literature DB >> 18082629

Fragments of obestatin as modulators of feed intake, circulating lipids, and stored fat.

ShreeRanga Nagaraj1, Muthukumar S Peddha, Uma V Manjappara.   

Abstract

Obestatin, shown to reduce feed intake and gain in body weight in rodents, is a very attractive candidate to be used against obesity. In this study, we aimed to investigate the relationship between the primary structure and activity of obestatin. Also of interest to us is a peptide of minimal length that closely mimics obestatin. Towards the same, we synthesized rodent obestatin and three overlapping fragments spanning residues 1-13, 6-18, and 11-23 of obestatin. These peptides subsequent to purification and characterization were tested upon adult male mice for their ability to reduce feed intake and gain in body weight. The N-terminal peptide (residues 1-13) mimicked obestatin the closest. The middle fragment (residues 6-18) significantly reduced epididymal fat without much altering feed intake or body weight.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082629     DOI: 10.1016/j.bbrc.2007.12.036

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Changes in feeding and drinking motivations and glucose content in male rats after single or chronic administration of obestatin or its fragment (1-4).

Authors:  E S Motorykina; E E Khirazova; M V Maslova; A S Maklakova; A V Graf; A A Bayzhymanov; O D Kurko; L A Zamyatina; L A Andreyeva; N A Sokolova; N F Myasoyedov; A A Kamenskii
Journal:  Dokl Biol Sci       Date:  2015-03-13

2.  The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling.

Authors:  Andrew J Agnew; Emma Robinson; Carmel M McVicar; Adam P Harvey; Imran H A Ali; Jennifer E Lindsay; Denise M McDonald; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Curr Protein Pept Sci       Date:  2011-06       Impact factor: 3.272

Review 4.  Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2009-11-26       Impact factor: 3.750

5.  The NMR structure of human obestatin in membrane-like environments: insights into the structure-bioactivity relationship of obestatin.

Authors:  Begoña O Alén; Lidia Nieto; Uxía Gurriarán-Rodríguez; Carlos S Mosteiro; Juan C Álvarez-Pérez; María Otero-Alén; Jesús P Camiña; Rosalía Gallego; Tomás García-Caballero; Manuel Martín-Pastor; Felipe F Casanueva; Jesús Jiménez-Barbero; Yolanda Pazos
Journal:  PLoS One       Date:  2012-10-04       Impact factor: 3.240

6.  Yin and Yang - the Gastric X/A-like Cell as Possible Dual Regulator of Food Intake.

Authors:  Andreas Stengel; Yvette Taché
Journal:  J Neurogastroenterol Motil       Date:  2012-04-09       Impact factor: 4.924

7.  Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC-MS metabolomics.

Authors:  Brian D Green; Stewart F Graham; Elaine Cowan; Praveen Kumar; Kerry J Burch; David J Grieve
Journal:  Metabolomics       Date:  2016-07-05       Impact factor: 4.290

Review 8.  Obestatin as a key regulator of metabolism and cardiovascular function with emerging therapeutic potential for diabetes.

Authors:  Elaine Cowan; Kerry J Burch; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2016-05-27       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.